To begin to understand the selective modulation of PPARγ by TZDs in ovarian cancer cells, we examined the mRNA and protein expression profiles of PPARγ and the activation of PPARγ's promoter following TZD treatment. This evidence concerns the gene PPARG and ovarian carcinoma.